Although Mycobacterium abscessus (M. abscessus) is becoming more prevalent in patients without overt immunodeficiency, little is known about the factors that contribute to disease susceptibility. This study was undertaken to investigate how Toll-like receptor 2 (TLR2) functionally contributes to the generation of protective immunity against M. abscessus in a morphotype-specific manner. We found that Tlr2 M ycobacterium abscessus (sensu stricto) is an emerging rapidly growing mycobacterium (RGM) that causes a wide spectrum of infections in humans, including lung, skin, soft tissue, and bone diseases (1). M. abscessus is the most drug-resistant mycobacterial pathogen, resulting in limited therapeutic options and a high rate of treatment failure (2).
M
ycobacterium abscessus (sensu stricto) is an emerging rapidly growing mycobacterium (RGM) that causes a wide spectrum of infections in humans, including lung, skin, soft tissue, and bone diseases (1) . M. abscessus is the most drug-resistant mycobacterial pathogen, resulting in limited therapeutic options and a high rate of treatment failure (2) .
Interestingly, the outcomes of mycobacterial infections can range from asymptomatic clearance to severe clinical disease (3) . Different pathogen-and host-specific factors have been considered in determining the outcomes of these infections. However, it is clear that the interaction between mycobacteria and the innate and adaptive immune systems plays a central role in host defense and pathogenesis (3) . In fact, the recognition of mycobacterial components by innate immune cells through various pattern recognition receptors (PRRs) induces a cytokine response that can promote early control of the infection (3, 4) .
Toll-like receptor (TLR)-mediated immune activation occurs only in the presence of functional TLRs, and TLR variants may exhibit altered expression, function, and recognition of signaling mechanisms, thereby increasing disease susceptibility. Healthy individuals who develop nontuberculous mycobacterial (NTM) diseases, including those caused by M. abscessus, likely have specific susceptibility factors that make them vulnerable to these infections (5) . Previous studies have demonstrated an association between human TLR2 polymorphisms and tuberculosis or Mycobacterium avium complex (MAC) lung disease (6) (7) (8) . In addition, TLR1 is required for TLR2 signaling, and the TLR1 single nucleotide polymorphism (SNP) I602S has been found in a cystic fibrosis cell line, resulting in a lack of recognition of M. abscessus rough variants by TLR2.
Furthermore, an age-associated decrease in TLR function has been identified (9) . The rate of M. abscessus infection has increased, predominantly in older women (5) . Thus, delineating the molecular recognition pattern of M. abscessus is important for understanding how host resistance is induced, maintained, and regulated during infection. To date, a limited number of in vivo studies have investigated the roles of innate immunity and adaptive immunity in M. abscessus infections (10) (11) (12) (13) .
Based on colony morphology on solid growth medium, there are two major variants of M. abscessus: the smooth (S) and rough (R) morphotypes (12) . The cell walls of the S variant of M. abscessus are enriched with glycopeptidolipids (GPLs), and this variant is thought to be the predominant morphotype in the environment; however, the R variant is more likely to cause invasive disease and is considered more pathogenic because of its association with excessive inflammation upon TLR2 ligation (14) (15) (16) . Despite extensive research, no conclusive evidence of a link between innate and adaptive immunity to M. abscessus infections in a morphotype-dependent manner has been produced, especially in vivo. Therefore, an understanding of molecular immunity to M. abscessus infection is critical for the development of effective strategies to treat M. abscessus infection.
In the current study, we have found that TLR2 is essential for efficient control of hypervirulent M. abscessus R variant infection in mice and serves as an intermediary between the innate and adaptive immune responses. We also investigated the importance of dendritic cell (DC) activation through TLR2 signaling in the generation of early protective immunity, and we attempted DC therapy for M. abscessus infection for the first time.
injection. Some mice were intranasally (i.n.) infected with 9 ϫ 10 6 CFU/ mouse of M. abscessus R. At each postinfection time point, the mice were euthanized by CO 2 inhalation, and the lungs, livers, and spleens were aseptically collected for bacterial counts or immune cell analysis. The numbers of viable bacteria in the organs were determined by plating serial dilutions of organ homogenates onto 7H10-OADC agar plates. Colonies were counted after 5 days of incubation at 37°C. Differences between the groups are presented as the mean log 10 CFU counts Ϯ standard errors of the means (SEM) per group.
Histology. Tissue samples collected for histopathology were preserved in 10% neutral buffered formalin, embedded in paraffin, cut into 2-to 3-m sections, and stained with hematoxylin and eosin or acid-fast stain, as described previously (18, 19) . Two independent pathologists performed blinded examinations of tissue sections from infected animals at 7 and 14 days postinfection. Each section was scored as absent (0), mild (1), moderate (2), severe (3), or extremely severe (4) . The severity of the inflammatory response was scored on a scale of 0 to 4 based on lesion size and the number of lesions per field. Tissues with multiple large lesions in more than three fields were assigned a score of 4.
Antibodies and reagents. Recombinant mouse granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-4 (IL-4) were purchased from R&D Systems (Minneapolis, MN). The following antibodies were purchase from eBioscience (San Diego, CA, USA): fluorescein isothiocyanate (FITC)-conjugated monoclonal antibody (MAb) for CD11b and CD62L; allophycocyanin (APC)-conjugated MAb for F4/80 and CD11c; eFluor450-conjugated MAb for CD3; peridinin chlorophyll protein (PerCP)-Cy5.5-conjugated MAb for CD4 ϩ and CD8 ϩ ; phycoerythrin (PE)-conjugated MAb for Gr-1, CD80, CD86, major histocompatibility complex class I (MHC-I), MHC-II, and CD44; PE-Cy5-conjugated MAb for CD4 ϩ and CD8 ϩ ; and PE-Cy7-conjugated MAb for CD11c.
Cytokine measurement. The levels of gamma interferon (IFN-␥), tumor necrosis factor alpha (TNF-␣), IL-1␤, IL-10, and IL-12p70 were determined by enzyme-linked immunosorbent assay (ELISA) in bronchoalveolar lavage (BAL) fluid and serum collected at 2, 5, 7 and 14 days postinfection, according to the manufacturer's instructions (eBioscience). BAL fluid samples were harvested by infusing 1 ml of ice-cold PBS through a 25-gauge blunt needle into the lungs via the trachea, followed by gentle aspiration of this fluid into a syringe at 2, 5, 7, and 14 days postinfection (20) . BAL fluid and cells were separated by centrifugation at 13,000 ϫ g for 10 min at 4°C. The supernatants were carefully collected for ELISA, and the cell pellets were collected for flow cytometry.
Flow cytometry. Cells were washed in ice-cold flow cytometry buffer (2%, vol/vol, bovine serum albumin and 2 mM EDTA in PBS, pH 7.5), incubated with each antibody for 15 min, and washed twice with flow cytometry buffer. Data were acquired on a FACSCanto II flow cytometer (BD Biosciences, San Diego, CA, USA) and analyzed with FlowJo software (Tree Star, Inc., Ashland, OR, USA).
Preparation of CFAs. Culture filtrate antigens (CFAs) were prepared from cultures at the mid-log phase of growth after 2 weeks of incubation at 37°C, as described previously (21) . Briefly, cells grown in modified Watson-Reid medium (mWR; pH 6.0) were removed by centrifugation at 30,000 ϫ g for 30 min. After filtration through a 0.2-m-pore-size filter (Millipore), the filtrate was concentrated 40-to 50-fold using a Centricon Plus-80 filter unit (5-kDa-molecular-weight cutoff; Amicon, Beverly, MA, USA) and dialyzed five times in 10 mM PBS using a Slide-A-Lyzer dialysis cassette (Pierce, Rockford, IL, USA).
Generation and culture of DCs. Immature mouse bone marrow-derived DCs (BM-DCs) were generated as described previously (22) . Briefly, whole bone marrow cells isolated from C57BL/6, Tlr2 Ϫ/Ϫ , and Tlr4 Ϫ/Ϫ mice were washed with serum-free RPMI 1640 medium. The cells were plated in petri dishes and cultured at 37°C in the presence of 5% CO 2 using RPMI 1640 medium supplemented with 100 units/ml penicillinstreptomycin (Lonza, Basel, Switzerland), 10% fetal bovine serum (Lonza, Basel, Switzerland), 50 M mercaptoethanol (Lonza), 20 ng/ml GM-CSF, and 5 ng/ml IL-4. On day 6, over 80% of the nonadherent cells expressed CD11c. To obtain highly purified populations for subsequent analyses, the DCs were labeled with bead-conjugated anti-CD11c MAb (Miltenyi Biotec, Bergisch Gladbach, Germany), followed by positive selection on paramagnetic columns (LS columns; Miltenyi Biotec) according to the manufacturer's instructions. The purity of the cell fraction selected was Ͼ95%.
Mixed lymphocyte reaction (MLR).
Responder T cells, which participate in allogeneic T-cell reactions, were isolated using a magnetic cell sorting (MACS) column (Miltenyi Biotec) from total mononuclear cells prepared from BALB/c mice. Ovalbumin (OVA)-specific CD8 ϩ and CD4 ϩ T cells (responders) were obtained from splenocytes of OT-1 and OT-2 mice, respectively. These T cells were stained with 1 M carboxyfluorescein diacetate succinimidyl ester (CFSE; Invitrogen, Carlsbad, CA, USA) as previously described (22) . DCs treated with OVA peptide in the presence of 10 g/ml M. abscessus CFA for 24 h were cocultured with CFSE-stained CD8 ϩ and CD4 ϩ T cells at a DC/T-cell ratio of 1:10. On day 2 or 3 of coculture, the T cells were stained with PerCP-Cy5.5-conjugated anti-CD4
ϩ MAb, PE-Cy5-conjugated anti-CD4 ϩ MAb, and PE-Cy5-conjugated anti-CD8
ϩ MAb prior to analysis by flow cytometry. The supernatants were harvested and evaluated to determine the production of IFN-␥, IL-2, and IL-4 by ELISA.
DC immunotherapy. Mice were infected i.v. with M. abscessus R (1.0 ϫ 10 7 CFU/mouse) prior to the injection of immature DCs and M. abscessus CFA-treated BM-DCs (1.0 ϫ 10 6 ) via the tail vein on postinfection day 2. At each postinfection time point, the mice were euthanized by CO 2 inhalation, and their lungs were aseptically collected for bacterial counts and histopathological analysis. The numbers of viable bacteria in the lungs were determined as described above. Each experiment was carried out twice.
Statistical analysis. All experiments were repeated at least three times with consistent results. Significant differences between samples were determined with Tukey's multiple-comparison tests using statistical software (GraphPad Prism software, version 4.03; GraphPad Software, San Diego, CA, USA). The data in the graphs are expressed as the means Ϯ SEM, and P values of Ͻ0.05, Ͻ0.01, and Ͻ0.001 were considered statistically significant. Survival curves were analyzed using a Kaplan-Meyer log rank test. 1A ). In contrast, there was no significant difference in mortality rates among the three mouse strains infected with the low dose of M. abscessus S; all mice survived until day 15 (see Fig. S1A in the supplemental material). When the mice were infected with a high dose of M. abscessus R, WT and Tlr4 Ϫ/Ϫ mice died within 12 days postinfection. Interestingly, all Tlr2 Ϫ/Ϫ mice died within 5 days postinfection (Fig. 1B) . We further assessed the growth of M. abscessus in the lungs, spleen, and liver after bacterial infection. When the mice were infected with a low dose of bacteria, bacterial loads in the lungs were slightly elevated at 7 days postinfection in all mouse strains, with no significant difference among the strains (Fig. 1C) . The levels of bacteria in the lungs of WT and Tlr4 Ϫ/Ϫ mice slowly decreased beginning at 7 days postinfection. In contrast, the bacteria in the lungs of Tlr2 Ϫ/Ϫ mice grew in an unrestricted manner until 19 days postinfection (Fig. 1C) . Similar results were obtained with the high-dose M. abscessus R infection (Fig. 1D ). The numbers of bacteria in the spleen and liver of WT and Tlr4 Ϫ/Ϫ mice decreased continuously by 19 days postinfection; however, bacterial numbers in the spleen and liver of Tlr2 Ϫ/Ϫ mice increased or did not change (see Fig. S2A and B in the supplemental material). In contrast, bacterial CFU counts in the lungs decreased continuously in mice infected with a high dose of M. abscessus S, and the mice survived until the end of the experiment (see Fig. S1A and B). Histopathological analysis revealed welldefined granulomatous lesions in WT mice in the early stages of infection (day 7). In comparison, no definitive granuloma was observed in the lungs of Tlr2 Ϫ/Ϫ mice. As the infection progressed in WT mice, the granulomatous lesions disappeared. In contrast, lesions with multifocal infiltration of most types of immune cells were found in the lungs of Tlr2 Ϫ/Ϫ mice (Fig. 1E ). The inflammation score reached 3 to 3.5 in the lungs of WT mice at 7 days postinfection. This score was significantly higher than that in Tlr2 Ϫ/Ϫ mice. However, at 14 days postinfection, the inflammation score in the lungs was higher in Tlr2 Ϫ/Ϫ mice than in WT mice (Fig. 1F) .
RESULTS

TLR2
To further investigate the importance of TLR2 in the relationship between the route of infection and susceptibility to M. abscessus, we challenged WT and Tlr2 Ϫ/Ϫ mice i.n. with M. abscessus R and examined bacterial CFU counts and histological changes in the lungs over 20 days. At 10 days postinfection, bacterial loads in the lungs were significantly increased in Tlr2 Ϫ/Ϫ mice compared with levels in WT mice (see Fig. S3A and B in the supplemental material). While WT mice eliminated M. abscessus R efficiently until 20 days postinfection, Tlr2 Ϫ/Ϫ mice failed to do so (see Fig.  S3A ). Histopathological analysis revealed that most Tlr2 Ϫ/Ϫ mice displayed a multifocal-to-coalescing well-delineated inflammatory lesion centered on the bronchioles and secondarily extending to the alveoli, leading to a complete loss of alveolar spaces. The alveolar spaces were filled by various immune cells, including lymphocytes, neutrophils, and macrophages, until 20 days postinfection. In contrast, WT mice displayed focal inflammatory lesions at 10 days postinfection, most of which had disappeared at 20 days (see Fig. S3C ). As shown in Fig. S3D in the supplemental material, the inflammation score reached 2 to 2.5 in the lungs of Tlr2 Ϫ/Ϫ mice at 10 and 20 days postinfection, which was significantly higher than that in the lungs of WT mice (score of 0 to 0.5). Accordingly, we concluded that TLR2 is crucial for protection against M. abscessus R and that Tlr2 Ϫ/Ϫ mice are extremely susceptible to i.v. infection by M. abscessus R.
TLR2 participates in macrophage activation but not in intracellular control of M. abscessus. Although the above results indicated that TLR2 is a key factor for the regulation of M. abscessus R in mice, we could not exclude the possibility that TLR2 has a direct effect on the ability to control bacterial growth or cytokine production in the infected macrophages. To test this hypothesis, we infected WT, Tlr2 Ϫ/Ϫ , and Tlr4 Ϫ/Ϫ bone marrow-derived macrophages (BMDMs) with M. abscessus S and M. abscessus R and measured intracellular growth for 72 h. The intracellular growth of S and R variants in Tlr2 Ϫ/Ϫ BMDMs was similar to that in WT and Tlr4 Ϫ/Ϫ cells (see Fig. S4A and B in the supplemental material); however, the production of TNF-␣ and IL-10 by Tlr2
BMDMs infected with R variants was significantly (P Ͻ 0.001) lower than that in WT and Tlr4 Ϫ/Ϫ BMDMs. In contrast, no dif-ference in the production of these cytokines was observed in cells infected with M. abscessus S (see Fig. S4C and D). TLR2 is involved in cytokine production in the bronchoalveolar lavage fluid of mice infected with M. abscessus R. To investigate whether TLR2 is involved in the production of inflammatory cytokines following infection with R variants, BAL fluid was obtained from infected mice at each time point, and the levels of IFN-␥, TNF-␣, IL-12p70, and IL-10 in the BAL fluid were measured by ELISA. The production of proinflammatory cytokines such as IFN-␥, TNF-␣, and IL-12p70 in the BAL fluid of WT and Tlr4 Ϫ/Ϫ mice increased significantly by 7 days postinfection and decreased to baseline levels after 14 days; however, significant changes in the levels of these cytokines were not observed until day 14 in Tlr2 Ϫ/Ϫ mice ( Fig. 2A) . The production of the anti-inflammatory cytokine IL-10 gradually increased, but there was no significant difference in the BAL fluid of WT and Tlr4 Ϫ/Ϫ mice until 14 days postinfection. In contrast, Tlr2 Ϫ/Ϫ mice displayed a rapid and significant increase in IL-10 levels between day 7 and day 14 postinfection (Fig. 2A) .
We further investigated whether TLR2 is involved in the production of inflammatory cytokines in serum following M. abscessus R infection. Serum was collected from infected mice at each time point, and the levels of IFN-␥, TNF-␣, IL-12p70, and IL-10 were measured by ELISA. The production of IFN-␥, TNF-␣, and IL-12p70 in the serum of WT and Tlr4 Ϫ/Ϫ mice increased by 2 days postinfection and returned almost to baseline after 7 days. In contrast, an increase in these cytokines was not observed until 14 days in Tlr2 Ϫ/Ϫ mice (see Fig. S5A to C in the supplemental material). IL-10 gradually increased in the serum of all experimental groups until 14 days postinfection (see Fig. S5D ). These results indicate that high levels of proinflammatory cytokine production may play an important role in the control of M. abscessus R variants in the early stages of infection and that TLR2 regulates the production of these cytokines.
TLR2 deficiency leads to decreased recruitment of inflammatory cells to the bronchoalveolar space in mice infected with M. abscessus R. To quantify inflammatory cell recruitment, BAL fluid was collected from WT, Tlr2 Ϫ/Ϫ , and Tlr4 Ϫ/Ϫ mice at 7 and 14 days after i.v. infection with M. abscessus R, and BAL cells retrieved from the BAL fluid were stained and counted to determine the types of cells recruited into the bronchoalveolar space. As shown in Fig. 2B to F high . Numbers indicate the percentages of cells in each quadrant. (F) The bar graph represents the absolute number of cells in each quadrant or square on days 7 and 14 after the initial infection. The results are presented as the means Ϯ SEM of each group (*, P Ͻ 0.05; **, P Ͻ 0.01; ***, P Ͻ 0.001).
CD4
ϩ and CD3 ϩ CD8 ϩ T cells in the bronchoalveolar space increased continuously from 7 to 14 days in WT and Tlr4 Ϫ/Ϫ mice. In contrast, recruitment of these cells was not observed until 14 days in Tlr2 Ϫ/Ϫ mice ( Fig. 2E and F) . These results indicate that TLR2 is essential for the recruitment of immune cells and the initiation of adaptive immunity against M. abscessus R.
TLR2 deficiency leads to decreased T-cell activation and IFN-␥ production during M. abscessus R infection. TLR2 was found to play a major role in the secretion of cytokines and the recruitment of various immune cells in mice infected with M. abscessus R. The role of TLR2 was determined by analyzing the expansion of and phenotypic changes in splenic T cells. The numbers of CD4 ϩ and CD8 ϩ cells were significantly increased in the spleens of WT and TLR4 Ϫ/Ϫ mice at 7 days, whereas these numbers were decreased by 14 days. In contrast, the percentages of CD4 ϩ and CD8 ϩ cells were not increased in Tlr2 Ϫ/Ϫ mice at 7 days postinfection but were elevated at 14 days postinfection (Fig. 3A) . These findings indicate that TLR2 is critical for inducing earlystage adaptive immunity. Similarly, the spleens of WT and Tlr4 Ϫ/Ϫ mice were greatly enlarged at day 7 compared with the spleens of Tlr2 Ϫ/Ϫ mice, which resembled those of uninfected mice (Fig. 3B) . Changes in naive and effector/memory T cells were determined by analyzing CD62L and CD44. CD62L low /CD44 high (effector and central memory) CD4 ϩ and CD8 ϩ T cells increased over time in WT and Tlr4 Ϫ/Ϫ mice; however, more naive T cells were detected in Tlr2 Ϫ/Ϫ mice ( Fig. 3C to F) . IFN-␥-producing T cells are essential for the control of M. abscessus infections in mice. To assess how the lack of TLR2 affected the development of this cell population, we measured the IFN-␥ production capacity of all spleen cells obtained from infected animals following stimulation with M. abscessus R CFA. The secretion of IFN-␥ also increased in WT and Tlr4 Ϫ/Ϫ mice; however, the IFN-␥ level was significantly lower in Tlr2 Ϫ/Ϫ mice despite treatment with CFA (see Fig. S6A and B in the supplemental material).
TLR2 plays a key role in DC activation by M. abscessus R and in T-cell proliferation. The data above show that TLR2 plays an important role in the impairment of T-cell expansion and activation in M. abscessus R infection. Therefore, TLR2 serves to link the innate and adaptive immune responses in the regulation of M. abscessus infections. To test this hypothesis, the effects of TLR2 on the activation of DCs and on antigen presentation by DCs were investigated. First, BM-DCs were differentiated from WT, Tlr2 Ϫ/Ϫ , and Tlr4 Ϫ/Ϫ mice using GM-CSF/IL-4. To test the ability of M. abscessus to activate BM-DCs via TLR2, we treated BM-DCs with M. abscessus CFA or performed direct infection with M. abscessus and measured the expression of surface molecules and proinflammatory cytokines. As shown in Fig. 4A and B, surface molecule expression and proinflammatory cytokine secretion were enhanced in WT and Tlr4 Ϫ/Ϫ BM-DCs following treatment with M. abscessus CFA or direct infection with M. abscessus but were strongly diminished in Tlr2 Ϫ/Ϫ BM-DCs. To verify the effects of TLR2 on T-cell proliferation, we performed a syngeneic MLR assay using OT-I T-cell receptor (TCR) transgenic CD8 ϩ T cells and OT-II TCR transgenic CD4 ϩ T cells. Transgenic CFSE-labeled OVA-specific CD4 ϩ and CD8 ϩ T cells were cocultured with M. abscessus CFA-treated BM-DCs isolated from WT, Tlr2 Ϫ/Ϫ , and Tlr4 Ϫ/Ϫ mice. The results showed that BM-DCs from WT and Tlr4 Ϫ/Ϫ mice induced significantly greater CD4 ϩ and CD8 ϩ Tcell proliferation than Tlr2 Ϫ/Ϫ BM-DCs pulsed with M. abscessus CFA (Fig. 5A and B) . In addition, syngeneic CD4 ϩ and CD8 ϩ T cells primed with M. abscessus CFA-treated BM-DCs isolated from WT and Tlr4 Ϫ/Ϫ mice produced significantly (P Ͻ 0.001) higher levels of IFN-␥ and IL-2 than those primed with Tlr2 Ϫ/Ϫ BM-DCs ( Fig. 5C and D) ; however, the differences in IL-4 secretion levels between BM-DCs from WT, Tlr2 Ϫ/Ϫ , and Tlr4 Ϫ/Ϫ mice were barely detectable. These results support the hypothesis that TLR2 plays a key role in T-cell proliferation through the presentation of M. abscessus antigens and the conversion from innate to adaptive immunity.
Therapeutic intervention via activated dendritic cells. An analysis of the Tlr2
Ϫ/Ϫ mice infected with M. abscessus R suggests that TLR2 is part of an effective immune response and that TLR2 plays a key role in DCs in the conversion from innate immunity to adaptive immunity against M. abscessus R. To test this hypothesis, we transferred M. abscessus CFA-treated mature BM-DCs from WT mice to Tlr2 Ϫ/Ϫ mice infected with M. abscessus R. Unstimulated immature BM-DCs from WT mice were injected into Tlr2 Ϫ/Ϫ mice as a control, and the survival rates and bacterial CFU counts were monitored for 30 days (Fig. 6A) . While all M. abscessus R-infected Tlr2 Ϫ/Ϫ mice died within 25 days of infection, the recipient mice were almost completely protected against M. abscessus R (Fig. 6B) . In addition, bacterial CFU counts in the lungs were significantly reduced in the Tlr2 Ϫ/Ϫ mice receiving mature BM-DCs (Fig. 6C) . We further investigated the effect of CFAtreated mature BM-DCs from WT mice on the recruitment of inflammatory cells. As shown in Fig. 6D , the recruitment of monocytes, DCs, CD11b mid DCs, CD11b high macrophages, neutrophils, and CD4 ϩ T and CD8 ϩ T lymphocytes into the bronchoalveolar space was markedly increased in the recipient mice compared with levels in Tlr2 Ϫ/Ϫ mice at 7 days postinfection. The recipient mice also showed significantly increased cytokine responses, which reached levels comparable to those observed in Tlr2 Ϫ/Ϫ mice (Fig. 6E) . Finally, to determine whether CFA-treated mature BM-DCs could enhance adaptive immunity in Tlr2 Ϫ/Ϫ mice, we isolated splenocytes from each group of mice and analyzed the changes in spleen size, CD4 T cells, and the CD8 effector/ memory T lymphocyte ratio. As shown in Fig. 6F , the spleens were substantially larger in the recipient mice than in Tlr2 Ϫ/Ϫ mice at day 7. Levels of CD62L low /CD44 high (effector and central memory) CD4
ϩ and CD8 ϩ T cells were markedly increased in the recipient mice compared with those in Tlr2 Ϫ/Ϫ mice (Fig. 6G ). These results strongly suggest that TLR2 from DCs plays a key role in the conversion from innate immunity to adaptive immunity during infection with M. abscessus R. DC therapy is likely to be an excellent approach for the treatment of M. abscessus.
DISCUSSION
In this study, we investigated the functional role of TLR2 in the generation of early protective immunity against M. abscessus. We found that TLR2 contributes to the initiation of Th1-type T-cell immunity rather than to the innate killing of mycobacteria. Macrophage infection with an M. abscessus S or R variant did not differ among WT, Tlr2 Ϫ/Ϫ , and Tlr4 Ϫ/Ϫ mice in terms of intracellular CFU counts (see Fig. S4 in the supplemental material) . Nevertheless, the recognition of M. abscessus R variants by TLR2 is crucial for the production of TNF-␣ and IL-12p70 from both macrophages and DCs. Interestingly, TLR2 did not affect cytokine production in response to M. abscessus S. This result was consistent with a previous study showing that GPL in the outermost layer of the M. abscessus cell wall masks the role of underlying cell wall lipids that are involved in stimulating the innate immune response through TLR2 (23) . In addition, our results suggest that a particular mycobacterial morphotype is associated with a specific disease phenotype and that the effective control of this morphotype requires a more efficient immune response (23, 24) .
Most innate immune cells such as neutrophils and macrophages are rapidly recruited to the site of a mycobacterial infection, where they recognize the pathogens and initiate and regulate immune responses. The ability of phagocytes to kill mycobacteria in vivo most likely depends on the tissue microenvironment, stage of infection, individual host, and infecting organism. The interaction of phagocytes with other cells and the downstream effects on T-cell activity could result in a range of outcomes, from early clearance of infection to the dissemination of viable bacteria and an attenuated acquired immune response. In Tlr2 Ϫ/Ϫ mice with established disease, neutrophils, monocytes, DCs, and macrophages accumulate under conditions of high pathogen load or immunological dysfunction in the later stages of infection. These cells are likely to contribute to pathology.
The development and progression of M. abscessus-related lung disease may depend on the balance between bacterial virulence and host defense. Mycobacterial virulence and host predisposition influence the progression of lung disease mediated by nontuberculous mycobacteria, including M. abscessus. Nevertheless, many reports have revealed that rough variants tend to be more virulent in experimental infections. Previous studies have suggested that the hyperlethality of rough M. abscessus strains may be related to mediators of the host innate response via TNF-␣ (23). In addition, overproduction of TNF-␣ may directly participate in immunopathological reactions or reflect a dysregulated immune response; however, the production of TNF-␣ in response to mycobacterial infection orchestrates the early induction of chemokines and is required for the coordination of leukocytes recruited into granulomas (25) . It is obvious that TLR2 contributes to the host defense mechanisms that control M. abscessus infection for several reasons. First, Tlr2 Ϫ/Ϫ mice were extremely susceptible to infection by the M. abscessus rough strain. Second, Tlr2 Ϫ/Ϫ mice infected with M. abscessus rough strains displayed uncontrolled bacterial burdens. Finally, the reconstitution of TLR2 WT DCs enabled Tlr2 Ϫ/Ϫ mice to control infection by a hypervirulent rough morphotype of M. abscessus. Thus, TLR2-mediated immune responses are protective rather than pathological host responses.
The uncontrolled infection in Tlr2
Ϫ/Ϫ mice resulted from the noninduction of immune effectors. First, Tlr2 Ϫ/Ϫ mice systemically and locally failed to produce crucial cytokines (IFN-␥, TNF-␣, and IL-12p70) to generate Th1-polarized immunity. Impaired TLR2 expression resulted in decreased IL-12 and TNF-␣ production in NTM lung disease, which contributed to host susceptibility (26, 27) . In addition, researchers using the same M. abscessus infection model (IFN-␥ receptor-1 KO mice and TNF-␣ KO mice) found that mice with either genetic disruption had significantly more M. abscessus bacteria in their livers and spleens than WT mice (11, 13) . TNF-␣ and IFN-␥ were thus shown to be essential in the host defense against M. abscessus in mice. Second, early recruitment of neutrophils, macrophages, and DCs into the lungs failed in Tlr2 Ϫ/Ϫ mice infected with the M. abscessus rough variant. Interestingly, in a murine model of infection with Mycobacterium fortuitum, which is similar to M. abscessus, the early neutrophilic response was an important contributor to infection control (28) . Although increased neutrophilic infiltration in the lungs was observed in leptin-deficient ob/ob mice, which were more susceptible to infection with aerosolized M. abscessus (11) , whether neutrophils were important in the host defense or the pathogenesis of M. abscessus lung infection was not specifically addressed; however, the delayed influx of neutrophils, macrophages, and DCs into the lungs of Tlr2 Ϫ/Ϫ mice clearly indicates that these immune cells are more likely related to host defense. Notably, immune cells involved in the innate immune response may not be directly involved in regulating bacterial infections as no differences were noted in bacterial counts among WT, Tlr2 (30) . Thus, we concluded that the absence of TLR2 signaling in M. abscessusinfected DCs leads to the failure to initiate T-cell immune responses. Less IFN-␥ is thus released, resulting in a failure to activate mycobacterium-containing macrophages to kill mycobacteria.
Notably, systemic administration of CFA-treated syngeneic DCs from WT mice ex vivo greatly strengthened immune priming in vivo, inducing a dramatic reduction in bacterial CFU and enhancing long-term survival in Tlr2 Ϫ/Ϫ mice infected with the hypervirulent M. abscessus rough variant. Our findings highlight the essential contribution of TLR2 to protective Th1-type immunity during M. abscessus infection in a morphotype-dependent manner. Importantly, injecting DCs into WT mice did not accelerate the generation of protective immunity against a rough variant of M. abscessus in terms of bacterial CFU counts as normal host defense mechanisms were sufficient to prevent infection. Thus, activated DCs are not necessary for controlling mycobacteria because host immune responses can adequately contain mycobacterial infection in WT mice. Alternative immunotherapeutics using activated DCs may therefore be warranted for M. abscessus treatment if TLR2 variants are detected. The high therapeutic response rates attained with M. abscessus-targeted Th1-type T-cell immunity as a result of CFA-stimulated DCs in a model of severe infection suggest that the effectiveness and specificity of DCs can be harnessed to treat M. abscessus. Immunotherapy may be of clinical importance in the development of new treatments and targeted interventions for difficult to treat pathogens. Thus, optimal conditions for generating potent immunostimulatory DCs that overcome antibiotic resistance and immune suppression are key factors in DC-based M. abscessus immunotherapy. DC-dependent aspects of the optimal immune response contribute to resolving infections and could also represent a compensatory host mechanism in the face of uncontrolled bacterial replication. The ideas presented in this study might ultimately be of importance for patients. Their early defensive function and potential contribution to disease progression may make DCs especially significant.
In conclusion, this study provides essential evidence that TLR2 plays a crucial role in the initiation of protective immune responses against a rough morphotype of M. abscessus by activating innate immune cells and polarizing the development of T cells to generate a Th1 response. The development of specific agents that compensate for the TLR2 signaling pathway may be useful in the design of new strategies to prevent chronic diseases caused by rough morphotypes of M. abscessus. The successful use of DC immunotherapy in the treatment of M. abscessus will open avenues for the development of new immunotherapeutic strategies and better clinical outcomes.
